ICD-10-CM Billable Code

C50.511

Malignant neoplasm of lower-outer quadrant of right female breast

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the lower-outer quadrant of the right female breast is a type of breast cancer that originates in the glandular tissue of the specified area. As a form of breast carcinoma, it involves abnormal and uncontrolled growth of cells, which can potentially invade surrounding tissues and spread to other parts of the body. Early detection and treatment are crucial for improving outcomes and quality of life.

Causes & Symptoms

Clinical Causes: Genetic mutations and family history of breast cancer Hormonal factors, such as prolonged exposure to estrogen Age, with increased risk as women grow older Lifestyle factors, including alcohol consumption, obesity, and physical inactivity Radiation exposure to the chest area Previous history of breast cancer or benign breast diseases Certain inherited gene mutations (e.g., BRCA1 and BRCA2)

Key Symptoms: Lump or mass in the lower-outer quadrant of the right breast Changes in the size, shape, or appearance of the breast Skin changes over the affected area, such as redness or dimpling Nipple alterations, including inversion, discharge, or pain Persistent pain in the breast or nipple Swelling or a lump in the armpit due to lymph node involvement A feeling of heaviness or discomfort in the breast

Diagnostic & Treatment

Diagnosis Path: Physical examination to assess the breast and lymph nodes Mammography for detailed imaging of breast tissue Ultrasound to evaluate the nature of detected lumps Biopsy, which involves removing a tissue sample for laboratory analysis to confirm malignancy Magnetic Resonance Imaging (MRI) for additional tissue assessment Hormone receptor testing and genetic profiling of the tumor

Treatment Protocols: Surgery, such as lumpectomy or mastectomy, to remove the tumor Radiation therapy to destroy remaining cancer cells post-surgery Chemotherapy to target cancer cells throughout the body Hormone therapy for hormone receptor-positive cancers Targeted therapy directed at specific genetic mutations or proteins Immunotherapy, in specific cases, to boost the body's immune response against the cancer

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.511 a billable ICD-10 code?
Yes, C50.511 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.511?
Clinical documentation must specify the nature of Malignant neoplasm of lower-outer quadrant of right female breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference